FINANCIAL CALENDAR FOR SCN 2009

(NGM:SCN)

The Board of Scandinavian Clinical Nutrition i Sverige AB (publ) have decided on the following financial calendar for the company:

February 18 Year-end Report and Interim Report October-December (Q4, 2008)

April 1 Annual Report 2008

April 29 Annual General Meeting 2008

May 15 Interim Report January-March (Q1, 2009)

August 28 Interim Report April-June (Q2, 2009)

November 13 Interim Report July-September (Q3, 2009)

February 26, 2010 Year-end Report and Interim Report October-December (Q4, 2009)

For more information, please contact:

Thomas Christensen, CEO, tc@scnutrition.com, +47 922 55 444

Ulf Söderberg, Chairman of the Board, us@scnutrition.com, +46 708 13 22 81

Scandinavian Clinical Nutrition AB (publ) works in R&D and distribution of clinically tested, scientifically documented products within the field of nutrition (nutraceuticals). Established in 2006, SCN maintains a product portfolio with established trademarks, such as CUUR, Coldizin, Immulina, Membra7 and Ledactin. Core competence and strategic alliances, within both R&D and sales, in combination with innovative and clinically proven products, create good conditions for profitable growth both in Sweden and internationally. The shares of SCN are traded under the ticker “SCN” on Oslo Axess (www.osloaxess.no) and NGM Equity (www.ngm.se).For more information, please visit www.scnutrition.com.